Ji Ping Jiang

age ~57

from New York, NY

Get Report

Also known as:

Connected to:

Name / Title

Company / Classification

Phones & Addresses

Ji Jiang

Prudential Douglas Elliman Re

21545 Northern Blvd, Bayside, NY 11361
20918 Northern Blvd, Bayside, NY 11361
(718)6318900, (718)6318900, (718)6318900, (718)6318900

view source

view source

Location:

Greater New York City Area

Industry:

Insurance

Ketone Linked Benzothiazole Inhibitors Of Endothelial Lipase
view source
US Patent:

20150239879, Aug 27, 2015
Filed:

Sep 5, 2013
Appl. No.:

14/427105
Inventors:

- Princeton NJ, US
Heather Finlay - Skillman NJ, US
Carol Hui Hu - New Hope PA, US
Ji Jiang - West Windsor NJ, US
James A. Johnson - Pennington NJ, US
Soong-Hoon Kim - Titusville NJ, US
John Lloyd - Yardley PA, US
Brandon Parkhurst - Holland MI, US
Zulan Pi - Pennington NJ, US
Jennifer X. Qiao - Princeton NJ, US
Tammy C. Wang - Lawrenceville NJ, US
International Classification:

C07D 417/06
C07D 417/14
Abstract:

The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicament.

Pyrrolinone Carboxamide Compounds Useful As Endothelial Lipase Inhibitors
view source
US Patent:

20140228321, Aug 14, 2014
Filed:

Sep 24, 2012
Appl. No.:

14/346751
Inventors:

- Princeton NJ, US
Heather Finlay - Skillman NJ, US
Ji Jiang - West Windsor NJ, US
John Lloyd - Yardley PA, US
Carol Hui Hu - New Hope PA, US
Zulan Pi - Pennington NJ, US
George O. Tora - Langhorne PA, US
James Neels - Newtown PA, US
Jon J. Hangeland - Morrisville PA, US
Todd J. Friends - Bordentown NJ, US
Assignee:

BRISTOL-MYERS SQUIBB COMPANY - Princeton NJ
International Classification:

C07D 207/38
C07D 471/04
C07F 7/08
C07D 413/12
C07D 417/12
C07D 409/12
C07D 401/12
US Classification:

514 63, 548537, 514423, 548527, 514422, 546121, 514300, 546208, 514326, 5462787, 514343, 546183, 514299, 548131, 514364, 548165, 514367, 548110
Abstract:

The present invention provides compounds of Formula (I): (I), as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.